Salvina Therapeutics AG, a recently founded Swiss company, is developing new therapies to break efficacy ceilings in inflammatory and autoimmune diseases. The company has unlocked…
Basel, 20 September, 2023 – The Swiss biotech company TOLREMO therapeutics AG recently completed a successful Series A financing, bringing the total amount raised to…
What you need to know about building your biotech startup What do biotech entrepreneurs need to navigate the biotech landscape successfully? In the ”Beyond biotech”…